Simone Ronsisvalle Selected Research

Simone Ronsisvalle Research Topics

Disease

11	Pain (Aches) 02/2023 - 07/2007
7	Inflammation (Inflammations) 12/2022 - 07/2009
5	Chronic Pain 12/2020 - 07/2009
4	Neoplasms (Cancer) 01/2024 - 10/2020
4	Hyperalgesia 03/2014 - 07/2009
3	COVID-19 12/2022 - 01/2021
2	Melanoma (Melanoma, Malignant) 06/2023 - 11/2017
2	Infections 11/2021 - 05/2021
2	Virus Diseases (Viral Diseases) 05/2021 - 01/2021
2	Neuralgia (Stump Neuralgia) 09/2018 - 08/2013
2	Edema (Dropsy) 03/2014 - 02/2014
2	Prostatic Neoplasms (Prostate Cancer) 05/2011 - 01/2011
2	Cognitive Dysfunction 01/2011 - 05/2009
1	Brain Diseases (Brain Disorder) 04/2024
1	Diffuse Intrinsic Pontine Glioma 01/2024
1	Brain Neoplasms (Brain Tumor) 01/2024
1	Hyperglycemia 02/2023
1	Hypesthesia (Numbness) 02/2023
1	Diabetic Neuropathies (Diabetic Neuropathy) 02/2023
1	Herpes Simplex 01/2022
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 05/2021
1	Respiratory Tract Diseases (Respiratory Tract Disease) 05/2021
1	Cardiotoxicity 12/2020
1	Acute Pain 12/2020
1	Osteoarthritis 01/2019
1	Mood Disorders (Mood Disorder) 01/2011
1	Ischemia 04/2006
1	Reperfusion Injury 04/2006

Drug/Important Bio-Agent (IBA)

8	LigandsIBA 11/2017 - 05/2009
5	Opioid Analgesics (Opioids)IBA 02/2023 - 06/2012
4	CarrageenanIBA 03/2014 - 07/2009
3	Opioid Receptors (Opioid Receptor)IBA 02/2023 - 06/2012
3	Analgesics (Analgesic Drugs)IBA 02/2023 - 01/2012
3	Peptide Hydrolases (Proteases)FDA Link 05/2021 - 01/2019
3	Formaldehyde (Formol)FDA Link 12/2020 - 01/2017
3	NociceptinIBA 01/2012 - 07/2007
2	AntioxidantsIBA 01/2023 - 12/2022
2	Antiviral Agents (Antivirals)IBA 01/2022 - 01/2021
2	Protease Inhibitors (Protease Inhibitor)IBA 05/2021 - 01/2021
1	Tetrabenazine (Nitoman)FDA Link 04/2024
1	dipinacoline glutamateIBA 01/2024
1	TIC10 compoundIBA 01/2024
1	Serine Proteases (Serine Protease)IBA 01/2024
1	Cytotoxins (Cytolysins)IBA 01/2024
1	HarmalineIBA 01/2024
1	Fluorescent Dyes (Fluorescent Probes)IBA 06/2023
1	sigma-2 receptorIBA 06/2023
1	Adiponectin ReceptorsIBA 02/2023
1	Neuroprotective AgentsIBA 02/2023
1	PhytochemicalsIBA 01/2023
1	thiazolyl blueIBA 01/2023
1	LipopolysaccharidesIBA 12/2022
1	mangiferinIBA 12/2022
1	Virulence Factors (Pathogenicity Factors)IBA 11/2021
1	IronIBA 05/2021
1	Therapeutic UsesIBA 05/2021
1	Chelating AgentsIBA 05/2021
1	Darunavir (Prezista)FDA Link 01/2021
1	Chloroquine (Aralen)FDA LinkGeneric 01/2021
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2021
1	Ritonavir (Norvir)FDA Link 01/2021
1	Lopinavir FDA Link 01/2021
1	Serotonin (5 Hydroxytryptamine)IBA 12/2020
1	VaccinesIBA 10/2020
1	AdiponectinIBA 06/2019
1	LipidsIBA 06/2019
1	Inflammation MediatorsIBA 01/2019
1	Matrix Metalloproteinases (MMPs)IBA 01/2019
1	ZincIBA 01/2019
1	5-HT1A Serotonin ReceptorIBA 09/2018
1	BenzomorphansIBA 01/2012
1	mu Opioid Receptors (mu Opioid Receptor)IBA 01/2012
1	Morphine (MS Contin)FDA LinkGeneric 01/2012
1	J 113397IBA 01/2012
1	nocistatinIBA 01/2012
1	Proteins (Proteins, Gene)FDA Link 01/2012
1	Pentazocine (Talwin)FDA LinkGeneric 01/2011
1	Haloperidol (Haldol)FDA LinkGeneric 01/2011
1	EstersIBA 01/2011
1	4-phenylbutyric acid (Buphenyl)FDA Link 01/2011
1	Sigma-1 ReceptorIBA 01/2011
1	Histone Deacetylase InhibitorsIBA 01/2011
1	N- (2- (3,4- Dichlorphenyl)ethyl)- N,N',N'- trimethyl- 1,2- ethandiaminIBA 01/2011
1	(Nphe(1),Arg(14),Lys(15))N-OFQ NH(2)IBA 07/2009
1	192 IgG-saporinIBA 05/2009
1	Immunotoxins (Immunotoxin)IBA 05/2009
1	Cholinergic Agents (Cholinergics)IBA 05/2009
1	sigma Receptors (sigma Receptor)IBA 05/2009
1	AdamantaneIBA 04/2006
1	Retinaldehyde (Retinal)IBA 04/2006

Therapy/Procedure

3	Therapeutics 04/2024 - 12/2020
1	Immunotherapy 10/2020
1	Injections 01/2012